Publications Gemignani

Publications

	Publications (Prof. Gemignani):
	1. Characterization of novel 3'untranslated regions and related polymorphisms of the gene NPPC, encoding for the C-type natriuretic peptide. Melaiu O, Facioni MS, Cabiati M, Caruso R, Giannessi D, Landi S, Gemignani F, Del Ry S. Peptides. 2013 Mar 28;44C:93-99. doi: 10.1016/j.peptides.2013.03.012. PMID:23542429 Related citations 2. [Identification and characterization of microRNA involving in malignant pleural mesothelioma]. Bonotti A, Foddis R, Papa A, Bigotti M, de Santi C, Gemignani F, Landi S, Cristaudo A. G Ital Med Lav Ergon. 2012 Jul-Sep;34(3 Suppl):552-4. Italian. PMID:23405713 Related citations 3. Polymorphisms in regulators of xenobiotic transport and metabolism genes PXR and CAR do not affect multiple myeloma risk: a case-control study in the context of the IMMEnSE consortium. Martino A, Sainz J, Manuel Reis R, Moreno V, Buda G, Lesueur F, Marques H, García-Sanz R, Ríos R, Stein A, Dumontet C, Gemignani F, Maria Rossi A, Landi S, Jurado M, Petrini M, Jamroziak K, Campa D, Canzian F. J Hum Genet. 2013 Mar;58(3):155-9. doi: 10.1038/jhg.2012.149. Epub 2013 Jan 10. PMID:23303387 Related citations 4. Medullary thyroid carcinoma (MTC) and RET proto-oncogene: mutation spectrum in the familial cases and a meta-analysis of studies on the sporadic form. Figlioli G, Landi S, Romei C, Elisei R, Gemignani F. Mutat Res. 2013 Jan-Mar;752(1):36-44. doi: 10.1016/j.mrrev.2012.09.002. Epub 2012 Oct 8. Review. PMID:23059849 Related citations 5. Impact of polymorphic variation at 7p15.3, 3p22.1 and 2p23.3 loci on risk of multiple myeloma. Martino A, Campa D, Jamroziak K, Reis RM, Sainz J, Buda G, García-Sanz R, Lesueur F, Marques H, Moreno V, Jurado M, Ríos R, Szemraj-Rogucka Z, Szemraj J, Tjønneland A, Overvad K, Vangsted AJ, Vogel U, Mikala G, Kádár K, Szombath G, Varkonyi J, Orciuolo E, Dumontet C, Gemignani F, Rossi AM, Landi S, Petrini M, Houlston RS, Hemminki K, Canzian F. Br J Haematol. 2012 Sep;158(6):805-9. doi: 10.1111/j.1365-2141.2012.09244.x. Epub 2012 Jul 24. No abstract available. PMID:22823248 Related citations 6. Comprehensive investigation of genetic variation in the 8q24 region and multiple myeloma risk in the IMMEnSE consortium. Campa D, Martino A, Sainz J, Buda G, Jamroziak K, Weinhold N, Vieira Reis RM, García-Sanz R, Jurado M, Ríos R, Szemraj-Rogucka Z, Marques H, Lesueur F, Bugert P, Moreno V, Szemraj J, Orciuolo E, Gemignani F, Rossi AM, Dumontet C, Petrini M, Goldschmidt H, Landi S, Canzian F. Br J Haematol. 2012 May;157(3):331-8. Epub 2012 Feb 13. PMID:22590720 Related citations 7. MAP3K7 and GSTZ1 are associated with human longevity: a two-stage case-control study using a multilocus genotyping. Di Cianni F, Campa D, Tallaro F, Rizzato C, De Rango F, Barale R, Passarino G, Canzian F, Gemignani F, Montesanto A, Landi S, Rose G. Age (Dordr). 2012 May 11. PMID:22576335 Related citations 8. Role of variations within microRNA-binding sites in cancer. Landi D, Gemignani F, Landi S. Mutagenesis. 2012 Mar;27(2):205-10. doi: 10.1093/mutage/ger055. PMID:22294768 Free Article Related citations 9. Identification of candidate genes carrying polymorphisms associated with the risk of colorectal cancer by analyzing the colorectal mutome and microRNAome. Landi D, Gemignani F, Pardini B, Naccarati A, Garritano S, Vodicka P, Vodickova L, Canzian F, Novotny J, Barale R, Landi S. Cancer. 2012 Oct 1;118(19):4670-80. doi: 10.1002/cncr.27435. Epub 2012 Jan 26. PMID:22282400 Related citations 10. A review of transcriptome studies combined with data mining reveals novel potential markers of malignant pleural mesothelioma. Melaiu O, Cristaudo A, Melissari E, Di Russo M, Bonotti A, Bruno R, Foddis R, Gemignani F, Pellegrini S, Landi S. Mutat Res. 2012 Apr-Jun;750(2):132-40. doi: 10.1016/j.mrrev.2011.12.003. Epub 2011 Dec 15. Review. PMID:22198210 Related citations 11. Polymorphisms in xenobiotic transporters ABCB1, ABCG2, ABCC2, ABCC1, ABCC3 and multiple myeloma risk: a case-control study in the context of the International Multiple Myeloma rESEarch (IMMEnSE) consortium. Martino A, Campa D, Buda G, Sainz J, García-Sanz R, Jamroziak K, Reis RM, Weinhold N, Jurado M, Ríos R, Szemraj-Rogucka Z, Marques H, Szemraj J, Stein A, Kumar R, Orciuolo E, Gemignani F, Landi S, Goldschmidt H, Petrini M, Dumontet C, Canzian F, Rossi AM. Leukemia. 2012 Jun;26(6):1419-22. doi: 10.1038/leu.2011.352. Epub 2011 Dec 20. No abstract available. PMID:22182917 Related citations 12. Genetics and molecular epidemiology of multiple myeloma: the rationale for the IMMEnSE consortium (review). Martino A, Sainz J, Buda G, Jamroziak K, Reis RM, García-Sanz R, Jurado M, Ríos R, Szemraj-Rogucka Z, Marques H, Lesueur F, Moreno V, Orciuolo E, Gemignani F, Landi S, Rossi AM, Dumontet C, Petrini M, Campa D, Canzian F. Int J Oncol. 2012 Mar;40(3):625-38. doi: 10.3892/ijo.2011.1284. Epub 2011 Dec 6. Review. PMID:22159523 Related citations 13. In silico and in vitro analysis of rare germline allelic variants of RET oncogene associated with medullary thyroid cancer. Cosci B, Vivaldi A, Romei C, Gemignani F, Landi S, Ciampi R, Tacito A, Molinaro E, Agate L, Bottici V, Cappagli V, Viola D, Piaggi P, Vitti P, Pinchera A, Elisei R. Endocr Relat Cancer. 2011 Sep 20;18(5):603-12. doi: 10.1530/ERC-11-0117. Print 2011 Oct. PMID:21810974 Free Article Related citations 14. Two novel polymorphisms in 5' flanking region of the mesothelin gene are associated with soluble mesothelin-related peptide (SMRP) levels. Cristaudo A, Foddis R, Bonotti A, Simonini S, Vivaldi A, Guglielmi G, Bruno R, Gemignani F, Landi S. Int J Biol Markers. 2011 Apr-Jun;26(2):117-23. doi: 10.5301/JBM.2011.8332. PMID:21574151 Related citations 15. Evidences that the polymorphism Pro-282-Ala within the tumor suppressor gene WWOX is a new risk factor for differentiated thyroid carcinoma. Cancemi L, Romei C, Bertocchi S, Tarrini G, Spitaleri I, Cipollini M, Landi D, Garritano S, Pellegrini G, Cristaudo A, Pinchera A, Barale R, Elisei R, Landi S, Gemignani F. Int J Cancer. 2011 Dec 15;129(12):2816-24. doi: 10.1002/ijc.25937. Epub 2011 Apr 25. PMID:21520031 Related citations 16. Polymorphisms affecting micro-RNA regulation and associated with the risk of dietary-related cancers: a review from the literature and new evidence for a functional role of rs17281995 (CD86) and rs1051690 (INSR), previously associated with colorectal cancer. Landi D, Moreno V, Guino E, Vodicka P, Pardini B, Naccarati A, Canzian F, Barale R, Gemignani F, Landi S. Mutat Res. 2011 Dec 1;717(1-2):109-15. doi: 10.1016/j.mrfmmm.2010.10.002. Epub 2010 Oct 30. Review. PMID:20971123 Related citations 17. Prediction of the biological effect of polymorphisms within microRNA binding sites. Landi D, Barale R, Gemignani F, Landi S. Methods Mol Biol. 2011;676:197-210. doi: 10.1007/978-1-60761-863-8_14. PMID:20931399 Related citations 18. COMPASSS (COMplex PAttern of Sequence Search Software), a simple and effective tool for mining complex motifs in whole genomes. Maccari G, Gemignani F, Landi S. Bioinformatics. 2010 Jul 15;26(14):1777-8. doi: 10.1093/bioinformatics/btq258. Epub 2010 May 25. PMID:20501554 Free Article Related citations 19. DeltaN133p53 expression levels in relation to haplotypes of the TP53 internal promoter region. Bellini I, Pitto L, Marini MG, Porcu L, Moi P, Garritano S, Boldrini L, Rainaldi G, Fontanini G, Chiarugi M, Barale R, Gemignani F, Landi S. Hum Mutat. 2010 Apr;31(4):456-65. doi: 10.1002/humu.21214. PMID:20127977 Related citations 20. Genetic polymorphisms associated with outcome in multiple myeloma patients receiving high-dose melphalan. Dumontet C, Landi S, Reiman T, Perry T, Plesa A, Bellini I, Barale R, Pilarski LM, Troncy J, Tavtigian S, Gemignani F. Bone Marrow Transplant. 2010 Aug;45(8):1316-24. doi: 10.1038/bmt.2009.335. Epub 2009 Dec 7. PMID:19966851 Related citations 21. Detailed haplotype analysis at the TP53 locus in p.R337H mutation carriers in the population of Southern Brazil: evidence for a founder effect. Garritano S, Gemignani F, Palmero EI, Olivier M, Martel-Planche G, Le Calvez-Kelm F, Brugiéres L, Vargas FR, Brentani RR, Ashton-Prolla P, Landi S, Tavtigian SV, Hainaut P, Achatz MI. Hum Mutat. 2010 Feb;31(2):143-50. doi: 10.1002/humu.21151. PMID:19877175 Related citations 22. Polymorphisms in the putative micro-RNA-binding sites of mesothelin gene are associated with serum levels of mesothelin-related protein. Cristaudo A, Foddis R, Bonotti A, Simonini S, Vivaldi A, Guglielmi G, Bruno R, Landi D, Gemignani F, Landi S. Occup Environ Med. 2010 Apr;67(4):233-6. doi: 10.1136/oem.2009.049205. Epub 2009 Oct 26. PMID:19858537 Related citations 23. Meta- and pooled analyses of the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and colorectal cancer: a HuGE-GSEC review. Taioli E, Garza MA, Ahn YO, Bishop DT, Bost J, Budai B, Chen K, Gemignani F, Keku T, Lima CS, Le Marchand L, Matsuo K, Moreno V, Plaschke J, Pufulete M, Thomas SB, Toffoli G, Wolf CR, Moore CG, Little J. Am J Epidemiol. 2009 Nov 15;170(10):1207-21. doi: 10.1093/aje/kwp275. Epub 2009 Oct 21. Review. PMID:19846566 Free PMC Article Related citations 24. Risk of malignant pleural mesothelioma and polymorphisms in genes involved in the genome stability and xenobiotics metabolism. Gemignani F, Neri M, Bottari F, Barale R, Canessa PA, Canzian F, Ceppi M, Spitaleri I, Cipollini M, Ivaldi GP, Mencoboni M, Scaruffi P, Tonini GP, Ugolini D, Mutti L, Bonassi S, Landi S. Mutat Res. 2009 Dec 1;671(1-2):76-83. doi: 10.1016/j.mrfmmm.2009.09.003. Epub 2009 Sep 12. PMID:19751749 Related citations 25. Determining the effectiveness of High Resolution Melting analysis for SNP genotyping and mutation scanning at the TP53 locus. Garritano S, Gemignani F, Voegele C, Nguyen-Dumont T, Le Calvez-Kelm F, De Silva D, Lesueur F, Landi S, Tavtigian SV. BMC Genet. 2009 Feb 17;10:5. doi: 10.1186/1471-2156-10-5. PMID:19222838 Free PMC Article Related citations 26. Pooled analysis of NAT2 genotypes as risk factors for asbestos-related malignant mesothelioma. Betti M, Neri M, Ferrante D, Landi S, Biava A, Gemignani F, Bertolotti M, Mirabelli D, Padoan M, Ugolini D, Botta M, Bonassi S, Magnani C, Dianzani I. Int J Hyg Environ Health. 2009 May;212(3):322-9. doi: 10.1016/j.ijheh.2008.08.001. Epub 2008 Oct 1. PMID:18838334 Related citations 27. Genetic susceptibility to malignant pleural mesothelioma and other asbestos-associated diseases. Neri M, Ugolini D, Dianzani I, Gemignani F, Landi S, Cesario A, Magnani C, Mutti L, Puntoni R, Bonassi S. Mutat Res. 2008 Jul-Aug;659(1-2):126-36. doi: 10.1016/j.mrrev.2008.02.002. Epub 2008 Feb 23. Review. PMID:18420450 Related citations 28. Polymorphisms within micro-RNA-binding sites and risk of sporadic colorectal cancer. Landi D, Gemignani F, Naccarati A, Pardini B, Vodicka P, Vodickova L, Novotny J, Försti A, Hemminki K, Canzian F, Landi S. Carcinogenesis. 2008 Mar;29(3):579-84. doi: 10.1093/carcin/bgm304. Epub 2008 Jan 12. PMID:18192692 Free Article Related citations 29. DNA microarray based on arrayed-primer extension technique for identification of pathogenic fungi responsible for invasive and superficial mycoses. Campa D, Tavanti A, Gemignani F, Mogavero CS, Bellini I, Bottari F, Barale R, Landi S, Senesi S. J Clin Microbiol. 2008 Mar;46(3):909-15. Epub 2007 Dec 26. PMID:18160452 Free PMC Article Related citations 30. A catalog of polymorphisms falling in microRNA-binding regions of cancer genes. Landi D, Gemignani F, Barale R, Landi S. DNA Cell Biol. 2008 Jan;27(1):35-43. PMID:17941804 Related citations 31. Genetic susceptibility to malignant mesothelioma and exposure to asbestos: the influence of the familial factor. Ugolini D, Neri M, Ceppi M, Cesario A, Dianzani I, Filiberti R, Gemignani F, Landi S, Magnani C, Mutti L, Puntoni R, Bonassi S. Mutat Res. 2008 Mar-Apr;658(3):162-71. Epub 2007 Aug 10. Review. PMID:17904414 Related citations 32. Development of a sensitive and specific multiplex PCR method combined with DNA microarray primer extension to detect Betapapillomavirus types. Gheit T, Billoud G, de Koning MN, Gemignani F, Forslund O, Sylla BS, Vaccarella S, Franceschi S, Landi S, Quint WG, Canzian F, Tommasino M. J Clin Microbiol. 2007 Aug;45(8):2537-44. Epub 2007 Jun 20. PMID:17581938 Free PMC Article Related citations 33. Single tube genotyping of GSTM1, GSTT1 and TP53 polymorphisms by multiplex PCR. Bottari F, Landi S, Gemignani F. DNA Seq. 2006 Oct;17(5):396-9. PMID:17343214 Related citations 34. Polymorphisms of glutathione-S-transferase M1 and manganese superoxide dismutase are associated with the risk of malignant pleural mesothelioma. Landi S, Gemignani F, Neri M, Barale R, Bonassi S, Bottari F, Canessa PA, Canzian F, Ceppi M, Filiberti R, Ivaldi GP, Mencoboni M, Scaruffi P, Tonini GP, Mutti L, Puntoni R. Int J Cancer. 2007 Jun 15;120(12):2739-43. PMID:17290392 Related citations 35. Development of lung cancer before the age of 50: the role of xenobiotic metabolizing genes. Gemignani F, Landi S, Szeszenia-Dabrowska N, Zaridze D, Lissowska J, Rudnai P, Fabianova E, Mates D, Foretova L, Janout V, Bencko V, Gaborieau V, Gioia-Patricola L, Bellini I, Barale R, Canzian F, Hall J, Boffetta P, Hung RJ, Brennan P. Carcinogenesis. 2007 Jun;28(6):1287-93. Epub 2007 Jan 27. PMID:17259654 Free Article Related citations 36. Interleukin-4 and interleukin-4 receptor polymorphisms and colorectal cancer risk. Landi S, Bottari F, Gemignani F, Gioia-Patricola L, Guino E, Osorio A, de Oca J, Capella G, Canzian F, Moreno V; Bellvitge Colorectal Cancer Study Group. Eur J Cancer. 2007 Mar;43(4):762-8. Epub 2007 Jan 26. PMID:17258448 Related citations 37. DNA repair and cell cycle control genes and the risk of young-onset lung cancer. Landi S, Gemignani F, Canzian F, Gaborieau V, Barale R, Landi D, Szeszenia-Dabrowska N, Zaridze D, Lissowska J, Rudnai P, Fabianova E, Mates D, Foretova L, Janout V, Bencko V, Gioia-Patricola L, Hall J, Boffetta P, Hung RJ, Brennan P. Cancer Res. 2006 Nov 15;66(22):11062-9. PMID:17108146 Free Article Related citations 38. Polymorphisms within inflammatory genes and colorectal cancer. Landi S, Gemignani F, Bottari F, Gioia-Patricola L, Guino E, Cambray M, Biondo S, Capella G, Boldrini L, Canzian F, Moreno V. J Negat Results Biomed. 2006 Oct 24;5:15. PMID:17062130 Free PMC Article Related citations 39. Sequence variants in cell cycle control pathway, X-ray exposure, and lung cancer risk: a multicenter case-control study in Central Europe. Hung RJ, Boffetta P, Canzian F, Moullan N, Szeszenia-Dabrowska N, Zaridze D, Lissowska J, Rudnai P, Fabianova E, Mates D, Foretova L, Janout V, Bencko V, Chabrier A, Landi S, Gemignani F, Hall J, Brennan P. Cancer Res. 2006 Aug 15;66(16):8280-6. PMID:16912209 Free Article Related citations 40. Development of a sensitive and specific assay combining multiplex PCR and DNA microarray primer extension to detect high-risk mucosal human papillomavirus types. Gheit T, Landi S, Gemignani F, Snijders PJ, Vaccarella S, Franceschi S, Canzian F, Tommasino M. J Clin Microbiol. 2006 Jun;44(6):2025-31. PMID:16757593 Free PMC Article Related citations 41. Polymorphisms in genes of nucleotide and base excision repair: risk and prognosis of colorectal cancer. Moreno V, Gemignani F, Landi S, Gioia-Patricola L, Chabrier A, Blanco I, González S, Guino E, Capellà G, Canzian F. Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2101-8. PMID:16609022 Free Article Related citations 42. Effect of cruciferous vegetables on lung cancer in patients stratified by genetic status: a mendelian randomisation approach. Brennan P, Hsu CC, Moullan N, Szeszenia-Dabrowska N, Lissowska J, Zaridze D, Rudnai P, Fabianova E, Mates D, Bencko V, Foretova L, Janout V, Gemignani F, Chabrier A, Hall J, Hung RJ, Boffetta P, Canzian F. Lancet. 2005 Oct 29-Nov 4;366(9496):1558-60. PMID:16257343 Related citations 43. Polymorphisms of the dopamine receptor gene DRD2 and colorectal cancer risk. Gemignani F, Landi S, Moreno V, Gioia-Patricola L, Chabrier A, Guino E, Navarro M, Cambray M, Capellà G, Canzian F. Cancer Epidemiol Biomarkers Prev. 2005 Jul;14(7):1633-8. PMID:16030094 Free Article Related citations 44. A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of colorectal cancer. Landi S, Gemignani F, Moreno V, Gioia-Patricola L, Chabrier A, Guino E, Navarro M, de Oca J, Capellà G, Canzian F; Bellvitge Colorectal Cancer Study Group. Pharmacogenet Genomics. 2005 Aug;15(8):535-46. PMID:16006997 Related citations 45. A database of single-nucleotide polymorphisms and a genotyping microarray for genetic epidemiology of lung cancer. Landi S, Gemignani F, Monnier S, Canzian F. Exp Lung Res. 2005 Mar;31(2):223-58. PMID:15824023 Related citations 46. Generation of a DNA microarray for determination of E6 natural variants of human papillomavirus type 16. Gemignani F, Landi S, Chabrier A, Smet A, Zehbe I, Canzian F, Tommasino M. J Virol Methods. 2004 Aug;119(2):95-102. PMID:15158590 Related citations 47. A TP53 polymorphism is associated with increased risk of colorectal cancer and with reduced levels of TP53 mRNA. Gemignani F, Moreno V, Landi S, Moullan N, Chabrier A, Gutiérrez-Enríquez S, Hall J, Guino E, Peinado MA, Capella G, Canzian F. Oncogene. 2004 Mar 11;23(10):1954-6. PMID:14647431 Related citations 48. Evaluation of a microarray for genotyping polymorphisms related to xenobiotic metabolism and DNA repair. Landi S, Gemignani F, Gioia-Patricola L, Chabrier A, Canzian F. Biotechniques. 2003 Oct;35(4):816-20, 822, 824-7. PMID:14579748 Related citations 49. Systemically delivered antisense oligomers upregulate gene expression in mouse tissues. Sazani P, Gemignani F, Kang SH, Maier MA, Manoharan M, Persmark M, Bortner D, Kole R. Nat Biotechnol. 2002 Dec;20(12):1228-33. Epub 2002 Nov 11. PMID:12426578 Related citations 50. Temperature-dependent splicing of beta-globin pre-mRNA. Gemignani F, Sazani P, Morcos P, Kole R. Nucleic Acids Res. 2002 Nov 1;30(21):4592-8. PMID:12409448 Free PMC Article Related citations 51. Reliable detection of beta-thalassemia and G6PD mutations by a DNA microarray. Gemignani F, Perra C, Landi S, Canzian F, Kurg A, Tõnisson N, Galanello R, Cao A, Metspalu A, Romeo G. Clin Chem. 2002 Nov;48(11):2051-4. No abstract available. PMID:12406995 Free Article Related citations 52. High-level expression of hemoglobin A in human thalassemic erythroid progenitor cells following lentiviral vector delivery of an antisense snRNA. Vacek MM, Ma H, Gemignani F, Lacerra G, Kafri T, Kole R. Blood. 2003 Jan 1;101(1):104-11. Epub 2002 Aug 15. PMID:12393543 Free Article Related citations 53. A catalogue of polymorphisms related to xenobiotic metabolism and cancer susceptibility. Gemignani F, Landi S, Vivant F, Zienolddiny S, Brennan P, Canzian F. Pharmacogenetics. 2002 Aug;12(6):459-63. PMID:12172214 Related citations 54. Formation of micronuclei and of clastogenic factor(s) in patients receiving therapeutic doses of iodine-131. Ballardin M, Gemignani F, Bodei L, Mariani G, Ferdeghini M, Rossi AM, Migliore L, Barale R. Mutat Res. 2002 Feb 15;514(1-2):77-85. PMID:11815246 Related citations 55. Spontaneous and MNNG-induced reversion of an EGFP construct in HeLa cells: an assay for observing mutations in living cells by fluorescent microscopy. Gemignani F, Landi S, DeMarini DM, Kole R. Hum Mutat. 2001 Dec;18(6):526-34. PMID:11748845 Related citations 56. Chromosome aberrations in lymphocytes and clastogenic factors in plasma detected in Belarus children 10 years after Chernobyl accident. Gemignani F, Ballardin M, Maggiani F, Rossi AM, Antonelli A, Barale R. Mutat Res. 1999 Dec 13;446(2):245-53. PMID:10635348 Related citations 57. Sister chromatid exchange and micronucleus frequency in human lymphocytes of 1,650 subjects in an Italian population: II. Contribution of sex, age, and lifestyle. Barale R, Chelotti L, Davini T, Del Ry S, Andreassi MG, Ballardin M, Bulleri M, He J, Baldacci S, Di Pede F, Gemignani F, Landi S. Environ Mol Mutagen. 1998;31(3):228-42. PMID:9585261 Related citations 58. Chromosome aberrations in humans in relation to site of residence. Milillo CP, Gemignani F, Sbrana I, Carrozzi L, Viegi G, Barale R. Mutat Res. 1996 Aug 8;360(3):173-9. PMID:8692216 Related citations


	HOME